While recent comprehensive UK figures are not available, studies in Ireland' and Scotland2 suggest that retinopathy of prematurity (ROP) currently accounts for approximately 10% of childhood blindness. Retinal cryotherapy has been demonstrated to reduce the incidence of blindness following the onset of 'threshold' disease.3 However, retinal cryotherapy in premature neonates can result in ocular45 and systemic5 6 morbidity.
Early Japanese experience with xenon photocoagulation treatment of ROP,7 and extensive experience with the use of argon and diode laser photocoagulation for retinal neovascular conditions in adults lead us to consider binocular indirect ophthalmoscope (BIO) laser photocoagulation as an alternative treatment. We began to use BIO diode laser photocoagulation in 1991, initially as a supplement to cryotherapy. From mid 1992 onwards BIO diode laser photocoagulation was used as the primary treatment of all cases of threshold ROP and we report the anatomical and functional outcome of the 13 Materials and methods All infants in one regional neonatal intensive care unit who developed threshold ROP during the period November 1992-3 were studied. Screening examinations were performed from 31 weeks postmenstrual age at 2 weekly intervals, increasing to weekly intervals when any grade of retinopathy was detected. The international classification of ROP was used.8 Zone 2 was further subdivided into anterior, mid and posterior zone 2 for descriptive purposes. Posterior vessel dilatation and tortuosity were subdivided into mild, moderate, or severe 'plus' disease.
The treatment criteria were those used in the Cryo-ROP study.4 The 'threshold' for treatment was defined as grade 3 Informed consent was obtained in each case (Appendix). The treatment was performed in the neonatal intensive care unit, within a room screened for laser use. The pupils were dilated using drops of tropicamide 0.5% and phenylephrine 2-5% instilled 30 and 15 minutes before treatment.9 All infants were paralysed and ventilated using intravenous morphine and pancuronium, administered by a neonatologist. A Nidek 1200 BIO diode laser was used for all treatments. Treatment was directed to all avascular retina anterior to the ROP ridge. Burns were spaced with a gap of approximately half a burn width between each burn, using enough energy to produce light grey/cream burns, avoiding intense white, full thickness bums. Posterior areas were treated without scleral indentation, and higher energy was needed to treat these areas. More anterior areas were treated using scleral indentation. An irrigating vectis connected to a 2 ml syringe containing saline was found to be convenient for this purpose, allowing frequent irrigation of the cornea during treatment. All treatments were performed by one ophthalmologist (BWF).
Extubation was performed within 24 hours of treatment. Post-treatment eyedrops were not used. Babies were reviewed weekly until all ROP has resolved. Retreatment was performed if areas of grade 3 retinopathy persisted in association with areas of untreated retina.
Follow up examinations were performed at 6, 12, and 18 months corrected postnatal age. A favourable anatomical outcome was defined as a normal posterior fundus on BIO examination, carried out by one observer who had not performed the treatments (EW). Refraction was measured using retinoscopy by one Table 2 gives the retinopathy findings.
Twenty eyes had mid zone 2 disease and four had posterior zone 2 disease. Plus disease consisted of mild or moderately severe posterior vessel dilatation and tortuosity in all cases. Grade 3 ROP first appeared in the nasal retina of 15 eyes, the temporal retina of four eyes, and the nasal and temporal retina equally in six eyes. In baby 4 retinopathy was confined to the nasal retina initially, and only the nasal Table 3 summarises the treatments. The median number of bums applied to each eye was 1200, with a range of 350-2500. The power used was 0-3-0-6 W. All bums were of 0-2 second duration. The times to resolution of retinopathy and resolution of plus disease were similar. Plus disease resolved within 1 week in eight infants, 1-2 weeks in three infants, and 2-3 weeks in one infant. Baby 4 was retreated at 3 weeks, and retinopathy and plus disease then resolved within 1 week.
No operative or postoperative laser complications were noted. There were no systemic complications during treatment. Ten infants were extubated within 24 hours of treatment, one 36 hours, and one 48 hours after treatment. One baby developed Escherischia coli pneumonia and was ventilated for 1 week. No other systemic complications were noted. All eyes had favourable anatomical outcomes as defined in the Cryo-ROP study.10 Table 4 summarises the functional outcomes. The median age at follow up was 19-5 (range 9.7-25.5) months. Three children had strabismus, two infantile esotropia (babies 8 and 10), and one exotropia (baby 9). In all babies grating visual acuity using Keeler preferential looking cards was obtained. Visual acuity ranged from 2-9 to 14-5 cycles per degree. In six babies uniocular acuity in each eye was obtained and in seven babies only binocular acuity could be obtained. All babies fell within the Cryo-ROP definition of favourable acuity for 1 year of age (0-8 cycles per degree uniocular). Only one baby (baby 4) was myopic, with a refraction of -1 50 dioptres in each eye. All other babies had low degrees of hypermetropia. Our findings of early nasal quadrant retinopathy in the majority of infants confirms natural history data reported by Fielder. 19 We opted to perform all treatments in the neonatal intensive care unit using a 'general anaesthetic', following our experience with cryotherapy.5 Several centres have reported the use of sedation and topical anaesthetic for BIO diode laser photocoagulation.11-16 However, we have found the routine use of intravenous pancuronium and morphine with endotracheal intubation and ventilation allows optimal treatment conditions. Complete laser treatment cover of avascular retina can be consistently achieved in these conditions and our one retreatment was precipitated by development ofnew areas ofretinopathy rather than by areas 'missed' on primary treatment. The infants remained very stable during treatment and early extubation following treatment was normally possible. One infant developed pneumonia following treatment, but had had copious respiratory secretions for several days before treatment.
Discussion
We used a median number of 1200 burns per eye to cover completely all avascular retina from the ROP ridge to the ora serrata. This is more treatment than that reported from some other centres, 11 15 16 18 but we were aiming to treat all avascular retina at one session. In one baby retinopathy was confined to the nasal retina at the time of primary treatment and the temporal avascular retina was not treated (baby 4). However, grade 3 retinopathy subsequently developed in the temporal quadrants necessitating a second treatment session. We prefer to treat anteriorly up to the ora serrata in order to minimise the risk of iris neovascularisation and rubeotic glaucoma.20
There were no instances of significant ocular or systemic complications during treatment. Vitreous haemorrhage has been reported following BIO diode laser photocoagulation,12 14 as has choroidal haemorrhage12 15 'Plus' disease and active retinopathy resolved 1-2 weeks after treatment in all but one baby. The timescale of resolution of plus disease following treatment has not been widely reported but our findings are similar to those of one previous report.'1 The timescale of resolution of retinopathy following cryotherapy has not been formally reported but it is our impression that BIO diode laser photocoagulation and cryotherapy produce a similar rate of resolution of retinopathy.
The anatomical outcome of the small number of babies reported in this paper has been good. Other reports of BIO laser photocoagulation also appear to show a relatively low rate of anatomical failure. [11] [12] [13] [14] [15] [16] The Cryo-ROP study at 1 year follow up reported anatomical failure in 25 In summary, in our experience diode laser treatment appears to be as effective as cryotherapy with less morbidity. about 2 months after birth, and unhealthy blood vessels start to grow instead. These unhealthy blood vessels can cause scarring of the nerves inside the eyes and this can permanently damage the vision.
It is possible to treat babies who have unhealthy blood vessels growing in their eyes. The baby is given an anaesthetic while in the premature baby unit, and the unhealthy parts inside the eyes are treated with very mild burns. The burns get rid of the unhealthy blood vessels, and allow healthy blood vessels to grow instead. The burns are produced by shining flashes of a very bright light (laser light) into the eyes. The treatment is normally performed only once, but occasionally a repeat treatment is needed 2-3 weeks afterwards.
The treatment takes 2-3 weeks to work, and it is not until 1-2 months after the treatment that we know whether it has worked or not. In a few babies the treatment does not work and the baby ends up with poor vision or even blindness. However, in most babies the treatment does work, and these babies develop good vision, although spectacles may be needed when they are older.
